Automated immunoassay is a method to detect the presence of a specific element in the human body such as antigen, antibody, or pathogen.
Automated immunoassay is a method to detect the presence of a specific element in the human body such as antigen, antibody, or pathogen. The automated immunoassay works on the principle of antigen and antibody specificity reaction. It has been in use in the field of clinical chemistry from a long time.
Read Report Overview - https://www.transparencymarketresearch.com/automated-immunoassays-market.html
The pharmaceutical & biotechnology and food & beverage industries also use immunoassays for research and quality control. Automated immunoassay has enhanced the laboratory workflow by adding advantages such as auto restart functionality, quality control scheduling, reduced hands on operation, fast & more accurate results, and more reliable data.
Based on application, the global automated immunoassays market can be segmented into infectious diseases, oncology, endocrinology, calcium metabolism, and others. The infectious diseases segment is projected to grow at a rapid pace during the forecast period due to high prevalence of infectious diseases such as dengue, Ebola, and typhoid across the globe.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=57750
Moreover, demand for accurate results within short time is rising, which can only be possible through automated immunoassay. In terms of end-user, the global automated immunoassays market can be classified into hospitals, diagnostic laboratories, and others. The hospitals segment is anticipated to expand at a high CAGR during the forecast period, as large number of patients prefer diagnosis of diseases in hospitals due to the availability of various treatments and diagnostics under one roof.
Automated immunoassays are revolutionary treatment options for a number of diseases such as cardiovascular, UTI infection, endocrinology. These provide accurate diagnosis of diseases in short time. High prevalence and incidence rates of chronic and infectious diseases are expected to drive the global automated immunoassays market.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=57750
Moreover, high incidence rate of endocrinology diseases such as thyroid dysfunction and diabetes mellitus propel the automated immunoassays market. According to the International Diabetes Federation (IDF), 415 million people were affected with diabetes worldwide in 2015. However, development of alternative diagnostic methods such as molecular diagnostics is anticipated to hamper the growth of the automated immunoassays market.
In terms of region, the global automated immunoassays market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2017. The region is projected to account for significant automated immunoassays market share during the forecast period due to increase in investment in the development of new automated immunoassays for diagnosis of infectious diseases.
Pre Book Automated Immunoassays Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=57750<ype=S
According to the Centers for Disease Control and Prevention (CDC), 61 cases of Zika virus were reported in the U.S. in 2015, which rose to 5,102 in 2016. Rise in prevalence of orthopedic disorders and cardiovascular diseases in countries such as India and China and availability of advanced testing kits are likely to propel the market in Asia Pacific during the forecast period. Rapid rise in health care infrastructure and high prevalence of variable diseases such as Zika propel the market in Middle East & Africa.
Key players operating in the global automated immunoassays market are Siemens Healthineers, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Bayer AG, Bio-Rad laboratories, Inc., and among others.
Browse more Reports by Transparency Market Research:
Iron-deficiency Anemia Market: Increasing the risk of haemodilution in pregnancy drive the iron-deficiency anemia market. Changes in lifestyle are playing a major role in propelling the global iron-deficiency anemia market. The iron-deficiency anemia market can be segmented based on therapy, end-user, and region.
Vial Adaptors for Reconstitution Drug Market: The growing prevalence of infectious diseases, widening pool of geriatrics, and increasing safety concerns have all triggered a demand for vial adaptors for reconstitution drugs. According to the research report, the global vial adaptors for reconstitution drug market was valued at US$780 mn in 2015 and is expected to reach US$1.3 bn by the end of 2024.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/